ICAM1 and cancer: Furthermore, strategies for specific targeting of CTCs and homotypic CTC-CTC clusters via antibodies or antibody-drug conjugates must be exploited to inactivate drivers of cancer stemness and CTC clustering, such as ICAM1 (14), thereby blocking seeding and eliminating metastasis.